Lexicon Pharmaceuticals
LXRX
#6755
Rank
S$0.87 B
Marketcap
S$2.08
Share price
1.24%
Change (1 day)
135.43%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): S-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.24. In 2024 the company made an earnings per share (EPS) of S-$0.81 an increase over its 2023 EPS that were of S-$1.02.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.26-68.68%
2024S-$0.81-20%
2023S-$1.0231.15%
2022S-$0.78-0%
2021S-$0.7810.91%
2020S-$0.70-145.08%
2019S$1.55-206.09%
2018S-$1.46-5.74%
2017S-$1.55-10.95%
2016S-$1.742640%
2015S-$0.06367-96.34%
2014S-$1.74-2.53%
2013S-$1.78-9.09%
2012S-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$22.63-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$6.98-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$54.90-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.44 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$8.02-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.64 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.95 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.32-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$97.67 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA